Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome

被引：7

作者：

del-Pino, Rodrigo Aguirre ^{[1
,2
]}

Monahan, Rory C. ^{[1
,3
]}

Huizinga, Tom W. J. ^{[1
]}

Eikenboom, Jeroen ^{[4
]}

Steup-Beekman, Gerda M. ^{[1
,5
]}

机构：

[1] Leiden Univ Med Ctr, Dept Rheumatol, Leiden, Netherlands

[2] A Coruna Univ Hosp CHUAC, Div Rheumatol, Xubias Arriba 84, Galicia 15006, Spain

[3] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands

[4] Leiden Univ Med Ctr, Dept Internal Med, Div Thrombosis & Hemostasis, Leiden, Netherlands

[5] Haaglanden Med Ctr, Dept Rheumatol, The Hague, Netherlands

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 2024年 / 50卷 / 06期

关键词：

antiphospholipid syndrome; antiphospholipid antibody; thrombosis; risk factor; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTICARDIOLIPIN ANTIBODIES; VENOUS THROMBOEMBOLISM; SYNDROME SCORE; FOLLOW-UP; VITAMIN-D; CLASSIFICATION CRITERIA; CARDIOVASCULAR-DISEASE; CLINICAL-SIGNIFICANCE; RHEUMATOID-ARTHRITIS;

D O I：

10.1055/s-0043-1776910

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Persistence of serum antiphospholipid antibodies (aPL) is associated with a high thrombotic risk, both arterial and venous, and with pregnancy complications. Due to the potential morbidity and mortality associated with the presence of aPL, identifying and recognizing risk factors for the development of aPL and thrombosis in aPL carriers may help to prevent and reduce the burden of disease. Multiple elements are involved in the pathomechanism of aPL development and aPL-related thrombosis such as genetics, malignancy, and infections. This review will address the role of both well-known risk factors and their evolution, and of emerging risk factors, including COVID-19, in the development of aPL and thrombosis in aPL carriers.

引用

页码：817 / 828

页数：12

共 125 条

[1] Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis [J].

Abdel-Wahab, N. ;

Talathi, S. ;

Lopez-Olivo, M. A. ;

Suarez-Almazor, M. E. .

LUPUS, 2018, 27 (04) :572-583

[2] Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors [J].

Abdel-Wahab, Noha ;

Tayar, Jean H. ;

Fa'ak, Faisal ;

Sharma, Gaurav ;

Lopez-Olivo, Maria A. ;

Yousif, Abdelrahman ;

Shagroni, Tasneem ;

Al-Hawamdeh, Sami ;

Rojas-Hernandez, Cristhiam M. ;

Suarez-Almazor, Maria E. .

BLOOD ADVANCES, 2020, 4 (08) :1746-1755

[3] Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience [J].

Abu-Zeinah, Ghaith ;

Oromendia, Clara ;

DeSancho, Maria T. .

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (02) :233-239

[4] Markers of cardiovascular risk in patients with antiphospholipid syndrome: A meta-analysis of literature studies [J].

Ambrosino, Pasquale ;

Lupoli, Roberta ;

Di Minno, Alessandro ;

Iervolino, Salvatore ;

Peluso, Rosario ;

Di Minno, Matteo Nicola Dario .

ANNALS OF MEDICINE, 2014, 46 (08) :693-702

[5] Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis [J].

Ames, Paul R. J. ;

Merashli, Mira ;

Bucci, Tommaso ;

Pastori, Daniele ;

Pignatelli, Pasquale ;

Arcaro, Alessia ;

Gentile, Fabrizio .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11) :1-23

[6] Antibodies to anionic phospholipids and anti-β2-GPI:: Association with thrombosis and thrombocytopenia in systemic lupus erythematosus [J].

Amoroso, A ;

Mitterhofer, AP ;

Del Porto, F ;

Garzia, P ;

Ferri, GM ;

Galluzzo, S ;

Vadacca, M ;

Caccavo, D ;

Afeltra, A .

HUMAN IMMUNOLOGY, 2003, 64 (02) :265-273

[7] Vitamin D and antiphospholipid syndrome [J].

Andreoli, L. ;

Piantoni, S. ;

Dall'Ara, F. ;

Allegri, F. ;

Meroni, P. L. ;

Tincani, A. .

LUPUS, 2012, 21 (07) :736-740

[8] In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation [J].

Andrianova, Izabella A. ;

Ponomareva, Anastasiya A. ;

Mordakhanova, Elmira R. ;

Le Minh, Giang ;

Daminova, Amina G. ;

Nevzorova, Tatiana A. ;

Rauova, Lubica ;

Litvinov, Rustem I. ;

Weisel, John W. .

JOURNAL OF AUTOIMMUNITY, 2020, 107

[9] A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones [J].

Asscheman, Henk ;

Giltay, Erik J. ;

Megens, Jos A. J. ;

de Ronde, W. ;

van Trotsenburg, Michael A. A. ;

Gooren, Louis J. G. .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (04) :635-642

[10] Antiphospholipid Antibodies and Lipids in Hematological Malignancies [J].

Barreno-Rocha, Sonia Guadalupe ;

Guzman-Silahua, Sandra ;

Rodriguez-Davila, Sinai-del-Carmen ;

Gavilanez-Chavez, Guadalupe Estela ;

Cardona-Munoz, Ernesto German ;

Riebeling-Navarro, Carlos ;

Rubio-Jurado, Benjamin ;

Nava-Zavala, Arnulfo Hernan .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)

← 1 2 3 4 5 6 7 8 9 10 →